Interestingly, ASNase treatment or ASNS knockdown reciprocally activates p53 to induce cell cycle arrest and protect cells from apoptosis, suggesting a therapeutic approach (e.g. use of ASNase) for the treatment of p53-null tumours by interfering with asparagine synthesis. This evidence concerns the gene TP53 and neoplasm.